Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to evaluate how tumors in patients with non-small cell lung cancer respond to treatment with VELCADE alone versus VELCADE given with docetaxel and also to see what effects (good and bad) it has on you and your cancer.
Epistemonikos ID: 1fe0a6753ee992890a68f6a8b0bd4b52f29c20f3
First added on: May 04, 2024